Showing results 1 to 20 of 24
next >
| Preview | Issue Date | Title | Author(s) |
| 2016 | Allogeneic mesenchymal precursor cells promote healing in postero-lateral annular lesions and improve indices of lumbar intervertebral disc degeneration in an ovine model | Freeman, B.; Kuliwaba, J.; Jones, C.; Shu, C.; Colloca, C.; Zarrinkalam, M.; Mulaibrahimovic, A.; Gronthos, S.; Zannettino, A.; Howell, S. |
| 2005 | An in vitro osteoclast-forming assay to measure myeloma cell-derived osteoclast-activating factors | Zannettino, A.; Farrugia, A.; To, L.; Atkins, G.; Brown, R.; Joy Ho, P. |
| 2011 | Anticancer efficacy of Apo2L/TRAIL is retained in the presence of high and biologically active concentrations of osteoprotegerin in vivo | Zinonos, I.; Labrinidis, A.; Lee, M.; Liapis, V.; Hay, S.; Ponomarev, V.; Diamond, P.; Findlay, D.; Zannettino, A.; Evdokiou, A. |
| 2009 | Apo2L/TRAIL inhibits tumor growth and bone destruction in a murine model of multiple myeloma | Labrinidis, A.; Diamond, P.; Martin, S.; Hay, S.; Liapis, V.; Zinonos, I.; Sims, N.; Atkins, G.; Vincent, C.; Ponomarev, V.; Findlay, D.; Zannettino, A.; Evdokiou, A. |
| 2009 | Apomab, a fully human agonistic antibody to DR5, exhibits potent antitumor activity against primary and metastatic breast cancer | Zinonos, I.; Labrinidis, A.; Lee, M.; Liapis, V.; Hay, S.; Ponomarev, V.; Diamond, P.; Zannettino, A.; Findlay, D.; Evdokiou, A. |
| 1999 | Differential cell surface expression of the STRO-1 and alkaline phosphatase antigens on discrete developmental stages in primary cultures of human bone cells | Gronthos, S.; Zannettino, A.; Graves, S.; Ohta, S.; Hay, S.; Simmons, P. |
| 2008 | Does Apo2LTRAIL play any physiologic role in osteoclastogenesis? | Labrinidis, A.; Liapis, V.; Thai, L.; Atkins, G.; Vincent, C.; Hay, S.; Sims, N.; Zannettino, A.; Findlay, D.; Evdokiou, A. |
| 2006 | Evidence for reduced bone formation surface relative to bone resorption surface in female femoral fragility fracture patients | Tsangari, H.; Findlay, D.; Zannettino, A.; Pan, B.; Kuliwaba, J.; Fazzalari, N. |
| 2002 | Evidence for the maturation-dependent expression of an osteoclastogenic phenotype in human osteoblasts. | Atkins, G.; Zannettino, A.; Kostakis, P.; Pan, B.; Farrugia, A.; Evdokiou, A.; Findlay, D.; American Society for Bone and Mineral Research. Conference (24th : 2002 : San Antonio, Texas) |
| 2002 | Haemopoietic cells influence stromal cell gene expression during human osteoclast development | Atkins, G.; Haynes, D.; Zannettino, A.; Capone, M.; Crotti, T.; Findlay, D. |
| 2002 | Human osteoblasts are resistant to Apo2L/TRAIL-mediated apoptosis | Atkins, G.; Bouralexis, S.; Evdokiou, A.; Hay, S.; Labrinidis, A.; Zannettino, A.; Haynes, D.; Findlay, D. |
| 2005 | Human trabecular bone-derived osteoblasts support human osteoclast formation in vitro in a defined, serum-free medium | Atkins, G.; Kostakis, P.; Welldon, K.; Vincent, C.; Findlay, D.; Zannettino, A. |
| 2004 | Identification and clinical relevance of receptor activator of nuclear factor kappa B ligand expression of myeloma cells - Reply | Zannettino, A.; Pan, B.; Farrugia, A.; Atkins, G.; To, L. |
| 2007 | Metabolism of vitamin D₃ in human osteoblasts: Evidence for autocrine and paracrine activities of 1α,25-dihydroxyvitamin D₃ | Atkins, G.; Anderson, P.; Findlay, D.; Welldon, K.; Vincent, C.; Zannettino, A.; O'Loughlin, P.; Morris, H. |
| 2004 | NM_001004419 Homo sapiens C-type lectin domain family 2, member D (CLEC2D), transcript variant 2, mRNA | Hu, Y.; Atkins, G.; Zhou, H.; Myers, D.; Quinn, J.; Ly, C.; Gange, C.; Kartsogiannis, V.; Elliott, J.; Kostakis, P.; Zannettino, A.; Cromer, B.; McKinstry, W.; Findlay, D.; Gillespie, M.; Ng, K. |
| 2004 | NM_013269 Homo sapiens C-type lectin domain family 2, member D (CLEC2D), transcript variant 1, mRNA | Hu, Y.; Atkins, G.; Zhou, H.; Myers, D.; Quinn, J.; Ly, C.; Gange, C.; Kartsogiannis, V.; Elliott, J.; Kostakis, P.; Zannettino, A.; Cromer, B.; McKinstry, W.; Findlay, D.; Gillespie, M.; Ng, K. |
| 2005 | Osteoprotegerin (OPG) is localized to the Weibel-Palade bodies of human vascular endothelial cells and is physically associated with von Willebrand factor | Zannettino, A.; Holding, C.; Diamond, P.; Atkins, G.; Kostakis, P.; Farrugia, A.; Gamble, J.; To, L.; Findlay, D.; Haynes, D. |
| 2006 | RANK expression as a cell surface marker of human osteoclast precursors in peripheral blood, bone marrow, and giant cell tumors of bone | Atkins, G.; Kostakis, P.; Vincent, C.; Farrugia, A.; Houchins, J.; Findlay, D.; Evdokiou, A.; Zannettino, A. |
| 2005 | RANK expression in normal and malignant cells: a monoclonal antibody study | Kostakis, P.; Atkins, G.; Vincent, C.; Farrugia, A.; Findlay, D.; Evdokiou, A.; Zannettino, A.; Annual Meeting of the American Society for Bone and Mineral Research (27th : 2005 : Nashville, Tennessee) |
| 2003 | The expression of 25-hydroxyvitaminD 24-hydroxylase and 25-hydroxyvitaminD 1 alpha-hydroxylase in human osteoblasts | Atkins, G.; Anderson, P.; Morris, H.; Zannettino, A.; Kostakis, P.; Findlay, D.; Annual Meeting of the American Society for Bone and Mineral Research (25th : 2003 : Minnesota, USA ) |
